Filter (Type enter to validate)
  Cat_Number Product name Supplier Quantity Price Tech More
DS-MB-02741 Mouse Anti-Foot-and-Mouth Disease Virus Serotype O1 Ray Biotech 200 604 DS-MB-02741 Mouse Anti-Foot-and-Mouth Disease Virus Serotype O1 Ray Biotech 200 604
ASK
Publication
MD-14-0860 Mouse Anti-Foot and Mouth Disease Virus NS Antibodies Ray Biotech 1 mg 452 MD-14-0860 Mouse Anti-Foot and Mouth Disease Virus NS Antibodies Ray Biotech 1 mg 452
ASK
Publication
FDA902-2 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, 15 cases 45 cores, replaced by FDA902b-2; ihc Anti-Actin confirmed US Biomax 858 FDA902-2 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, 15 cases 45 cores, replaced by FDA902b-2; ihc Anti-Actin confirmed US Biomax 858
ASK
Publication
FDA901-1 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ. (slide one); ihc Anti-Actin confirmed US Biomax 858 FDA901-1 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ. (slide one); ihc Anti-Actin confirmed US Biomax 858
ASK
Publication
FDA901-2 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ. (slide two); ihc Anti-Actin confirmed US Biomax 858 FDA901-2 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ. (slide two); ihc Anti-Actin confirmed US Biomax 858
ASK
Publication
FRA901a Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation, 45 cases 45 cores, 2 slides set, replacing FRA901; ihc Anti-Actin confirmed US Biomax 858 FRA901a Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation, 45 cases 45 cores, 2 slides set, replacing FRA901; ihc Anti-Actin confirmed US Biomax 858
ASK
Publication
FDA902 FDA Standard Frozen Tissue Array (2 slide set), for therapeutic and diagnostic monoclonal antibody validation recommanded by FDA, 90 tissue cores of 30 organs, 3 individual donors per organ US Biomax 199 FDA902 FDA Standard Frozen Tissue Array (2 slide set), for therapeutic and diagnostic monoclonal antibody validation recommanded by FDA, 90 tissue cores of 30 organs, 3 individual donors per organ US Biomax 199
ASK
Publication
LF-MA0148 anti-Inter-α-trypsininhibitor (40B10), Mouse monoclonal to Inter-α-trypsininhibitor, Isotype IgG1, Host Mouse Abfrontier 100 ul 355 LF-MA0148 anti-Inter-α-trypsininhibitor (40B10), Mouse monoclonal to Inter-α-trypsininhibitor, Isotype IgG1, Host Mouse Abfrontier 100 ul 355 Publication
FDA902b FDA Standard Frozen Tissue Array (2 slide set), for therapeutic and diagnostic monoclonal antibody validation recommanded by FDA, 90 tissue cores of 30 organs, 3 individual donors per organ, replacing US Biomax 1206 FDA902b FDA Standard Frozen Tissue Array (2 slide set), for therapeutic and diagnostic monoclonal antibody validation recommanded by FDA, 90 tissue cores of 30 organs, 3 individual donors per organ, replacing US Biomax 1206
ASK
Publication
FRA901a-1 Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-1; ihc Anti-Actin c US Biomax 626 FRA901a-1 Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-1; ihc Anti-Actin c US Biomax 626
ASK
Publication
FRA901a-2 Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-2; ihc Anti-Actin c US Biomax 626 FRA901a-2 Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-2; ihc Anti-Actin c US Biomax 626
ASK
Publication
FDA901 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides.; ih US Biomax 1438 FDA901 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides.; ih US Biomax 1438
ASK
Publication
FDA902a FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides, rep US Biomax 1206 FDA902a FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides, rep US Biomax 1206
ASK
Publication
CTP-100 Laboratory supplies and fixtures: HD Clear(TM) Sealing Tape, 1.88 inches wide Jena Bioscience 1roll 42 CTP-100 Laboratory supplies and fixtures: HD Clear(TM) Sealing Tape, 1.88 inches wide Jena Bioscience 1roll 42
ASK
Publication
305-13451 Anti 3 DG imidazolone Monoclonal Antibody It has been shown that Advanced Glycation End products (AGEs) have been involved in chronic disease with aging, such as diabetes or brain disease. So far, sev B-Bridge 50 UG 958.65 305-13451 Anti 3 DG imidazolone Monoclonal Antibody It has been shown that Advanced Glycation End products (AGEs) have been involved in chronic disease with aging, such as diabetes or brain disease. So far, sev B-Bridge 50 UG 958.65
ASK
Publication
BAH68-1000 Diagnostic grade heat shock BSA powder, 1KG Equitech 1KG 773.598 BAH68-1000 Diagnostic grade heat shock BSA powder, 1KG Equitech 1KG 773.598
ASK
Publication
BAH68-0050 Diagnostic grade heat shock BSA powder, 50gm Equitech 50gm 310.863 BAH68-0050 Diagnostic grade heat shock BSA powder, 50gm Equitech 50gm 310.863
ASK
Publication
BAH68-0100 Diagnostic grade heat shock BSA powder, 100gm Equitech 100gm 403.41 BAH68-0100 Diagnostic grade heat shock BSA powder, 100gm Equitech 100gm 403.41
ASK
Publication
BAH68-0500 Diagnostic grade heat shock BSA powder, 500gm Equitech 500gm 557.655 BAH68-0500 Diagnostic grade heat shock BSA powder, 500gm Equitech 500gm 557.655
ASK
Publication
FMO901-2 Normal mouse multiple organ frozen tissue array, for therapeutic and diagnostic antibody, 15 organs 45 cores, slide 2 of 2 tissue arrays; ihc Anti-Actin confirmed US Biomax 626 FMO901-2 Normal mouse multiple organ frozen tissue array, for therapeutic and diagnostic antibody, 15 organs 45 cores, slide 2 of 2 tissue arrays; ihc Anti-Actin confirmed US Biomax 626
ASK
Publication
AR-0106-02 Newcastle Disease Virus (NDV) Real Time PCR Kit RNA III, IV Liferiver 25 349.65 AR-0106-02 Newcastle Disease Virus (NDV) Real Time PCR Kit RNA III, IV Liferiver 25 349.65
ASK
Publication
DS-MB-03442 Mouse Anti-Marek's Disease Virus Ray Biotech 200 604 DS-MB-03442 Mouse Anti-Marek's Disease Virus Ray Biotech 200 604
ASK
Publication
DS-MB-03465 Mouse Anti-Newcastle Disease Virus Ray Biotech 200 541 DS-MB-03465 Mouse Anti-Newcastle Disease Virus Ray Biotech 200 541
ASK
Publication
BRD181 Breast disease tissue array, 18 cases 18 cores US Biomax 118 BRD181 Breast disease tissue array, 18 cases 18 cores US Biomax 118
ASK
Publication
LUD151 Lung disease tissue array, 15 cases 15 cores US Biomax 166 LUD151 Lung disease tissue array, 15 cases 15 cores US Biomax 166
ASK
Publication
MD-05-0350 Mouse Anti-Newcastle Disease Virus (NDV) Antibodies Ray Biotech 1 mg 535 MD-05-0350 Mouse Anti-Newcastle Disease Virus (NDV) Antibodies Ray Biotech 1 mg 535 Publication
MD-14-0918 Mouse Anti-Marek Disease Virus Antibodies Ray Biotech 1 mg 568 MD-14-0918 Mouse Anti-Marek Disease Virus Antibodies Ray Biotech 1 mg 568
ASK
Publication
MD-14-1053 Rabbit Anti-B. burgdorferi (Lyme disease) Antibodies Ray Biotech 1 mL 386 MD-14-1053 Rabbit Anti-B. burgdorferi (Lyme disease) Antibodies Ray Biotech 1 mL 386
ASK
Publication
MD-14-1054 Rabbit Anti-B. burgdorferi (Lyme disease) Antibodies Ray Biotech 1 mL 386 MD-14-1054 Rabbit Anti-B. burgdorferi (Lyme disease) Antibodies Ray Biotech 1 mL 386
ASK
Publication
MD-14-1055 Rabbit Anti-B. burgdorferi (Lyme disease) Antibodies Ray Biotech 1 mL 370 MD-14-1055 Rabbit Anti-B. burgdorferi (Lyme disease) Antibodies Ray Biotech 1 mL 370
ASK
Publication
SKD241 Skin disease tissue array, 24 cases 24 cores US Biomax 166 SKD241 Skin disease tissue array, 24 cases 24 cores US Biomax 166
ASK
Publication
THD181 Thyroid disease tissue array, 18 cases 18 cores US Biomax 142 THD181 Thyroid disease tissue array, 18 cases 18 cores US Biomax 142
ASK
Publication
AGHIV-0210 rHIV gp36, insoluble Antigens - Infectious Disease Arista Bio 1-99 mg/ml/ea price x 2 510 AGHIV-0210 rHIV gp36, insoluble Antigens - Infectious Disease Arista Bio 1-99 mg/ml/ea price x 2 510
ASK
Publication
AGHIV-0215 rHIV gp36, soluble Antigens - Infectious Disease Arista Bio 1-99 mg/ml/ea price x 2 466 AGHIV-0215 rHIV gp36, soluble Antigens - Infectious Disease Arista Bio 1-99 mg/ml/ea price x 2 466
ASK
Publication
AGHIV-0225 rHIV gp41, soluble Antigens - Infectious Disease Arista Bio 1-99 mg/ml/ea price x 2 479 AGHIV-0225 rHIV gp41, soluble Antigens - Infectious Disease Arista Bio 1-99 mg/ml/ea price x 2 479
ASK
Publication
DID381 Digestive system disease tissue array, 38 cases 38 cores US Biomax 166 DID381 Digestive system disease tissue array, 38 cases 38 cores US Biomax 166
ASK
Publication
HND181 Head and neck disease tissue array, 18 cases 18 cores US Biomax 166 HND181 Head and neck disease tissue array, 18 cases 18 cores US Biomax 166
ASK
Publication
HNT961 Head and neck disease tissue array, 48 cases 96 cores US Biomax 225 HNT961 Head and neck disease tissue array, 48 cases 96 cores US Biomax 225
ASK
Publication
LUD481 Lung disease and normal tissue array, 16 cases 48 cores US Biomax 225 LUD481 Lung disease and normal tissue array, 16 cases 48 cores US Biomax 225
ASK
Publication
TH807 Thyroid disease spectrum tissue array, 75 cases 80 cores US Biomax 266 TH807 Thyroid disease spectrum tissue array, 75 cases 80 cores US Biomax 266
ASK
Publication
CVD231 Cardiovascular disease tissue array, non overlapping with CVD481, 23 cases 23 cores US Biomax 166 CVD231 Cardiovascular disease tissue array, non overlapping with CVD481, 23 cases 23 cores US Biomax 166
ASK
Publication
CVD481 Cardiovascular disease tissue array, no overlapping with CVD231, 24 cases 48 cores US Biomax 189 CVD481 Cardiovascular disease tissue array, no overlapping with CVD231, 24 cases 48 cores US Biomax 189
ASK
Publication
ES2081 Esophageal disease (progression) spectrum tissue array, 103 cases 208 cores US Biomax 456 ES2081 Esophageal disease (progression) spectrum tissue array, 103 cases 208 cores US Biomax 456
ASK
Publication
IPLA-DIBP Disease State Samples: Single Donor Human Diabetic Plasma Innovative Research INC 1ml 342 IPLA-DIBP Disease State Samples: Single Donor Human Diabetic Plasma Innovative Research INC 1ml 342 Publication
LP802 Laryngeal disease spectrum (progression) tissue array, 78 cases 80 cores US Biomax 278 LP802 Laryngeal disease spectrum (progression) tissue array, 78 cases 80 cores US Biomax 278
ASK
Publication
MD-14-0747 Mouse Anti-B. burgdorferi sensu stricto (Lyme disease) Antibodies Ray Biotech 1 mg 411 MD-14-0747 Mouse Anti-B. burgdorferi sensu stricto (Lyme disease) Antibodies Ray Biotech 1 mg 411
ASK
Publication
UGD381 Urinary genital system disease tissue array, 38 cases 38 cores US Biomax 166 UGD381 Urinary genital system disease tissue array, 38 cases 38 cores US Biomax 166
ASK
Publication
BC30013 Heart disease and normal tissue array, replacing BC30011, 18 cases 36 cores US Biomax 231 BC30013 Heart disease and normal tissue array, replacing BC30011, 18 cases 36 cores US Biomax 231
ASK
Publication
IPLA-ADPF Disease State Samples: Single Donor Human Atopic Dermatitis Plasma Innovative Research INC 1ml 342 IPLA-ADPF Disease State Samples: Single Donor Human Atopic Dermatitis Plasma Innovative Research INC 1ml 342
ASK
Publication
KD2084 Renal disease spectrum tissue array, with stage and TNM info, 104 cases 208 cores US Biomax 456 KD2084 Renal disease spectrum tissue array, with stage and TNM info, 104 cases 208 cores US Biomax 456
ASK
Publication
BL804 Bladder disease spectrum (urocystic cancer progression) tissue array, 80 cases 80 cores US Biomax 266 BL804 Bladder disease spectrum (urocystic cancer progression) tissue array, 80 cases 80 cores US Biomax 266
ASK
Publication
GA2081 Gallbladder disease spectrum (cholecystic cancer progression) tissue array, 103 cases 208 cores US Biomax 236 GA2081 Gallbladder disease spectrum (cholecystic cancer progression) tissue array, 103 cases 208 cores US Biomax 236
ASK
Publication
KD807 Kidney disease spectrum (renal cancer progression) tissue array, 80 cases 80 cores US Biomax 231 KD807 Kidney disease spectrum (renal cancer progression) tissue array, 80 cases 80 cores US Biomax 231
ASK
Publication
LC1201 Lung disease spectrum tissue array, 116 cases 120 cores, with grade and stage information US Biomax 278 LC1201 Lung disease spectrum tissue array, 116 cases 120 cores, with grade and stage information US Biomax 278
ASK
Publication
LC2083 Lung disease spectrum (pulmonary cancer progression) tissue array, 193 cases 208 cores US Biomax 456 LC2083 Lung disease spectrum (pulmonary cancer progression) tissue array, 193 cases 208 cores US Biomax 456
ASK
Publication
LC487 Lung disease spectrum tissue array, including TNM and pathology grade, 24 cases 48 cores US Biomax 225 LC487 Lung disease spectrum tissue array, including TNM and pathology grade, 24 cases 48 cores US Biomax 225
ASK
Publication
LC809 Lung disease spectrum (pulmonary cancer progression) tissue array, 78 cases 80 cores US Biomax 231 LC809 Lung disease spectrum (pulmonary cancer progression) tissue array, 78 cases 80 cores US Biomax 231
ASK
Publication
LV2081 Hepatic disease spectrum (liver cancer progression) tissue array, 103 cases 208 cores US Biomax 516 LV2081 Hepatic disease spectrum (liver cancer progression) tissue array, 103 cases 208 cores US Biomax 516
ASK
Publication
LV8011 Liver disease spectrum (hepatic cancer progression) tissue array, 76 cases 80 cores US Biomax 231 LV8011 Liver disease spectrum (hepatic cancer progression) tissue array, 76 cases 80 cores US Biomax 231
ASK
Publication
PR805 Prostate disease spectrum (prostatic cancer progression) tissue array, 80 cases 80 cores US Biomax 266 PR805 Prostate disease spectrum (prostatic cancer progression) tissue array, 80 cases 80 cores US Biomax 266
ASK
Publication
RE2081 Rectum disease spectrum (rectal cancer progression) tissue array, 98 cases 208 cores US Biomax 456 RE2081 Rectum disease spectrum (rectal cancer progression) tissue array, 98 cases 208 cores US Biomax 456
ASK
Publication
RE804 Rectal disease spectrum (rectum cancer progression) tissue array, 75 cases 80 cores US Biomax 231 RE804 Rectal disease spectrum (rectum cancer progression) tissue array, 75 cases 80 cores US Biomax 231
ASK
Publication
SK2081 Skin disease spectrum (dermatic cancer progression) tissue array, 102 cases 208 cores US Biomax 456 SK2081 Skin disease spectrum (dermatic cancer progression) tissue array, 102 cases 208 cores US Biomax 456
ASK
Publication
SK805 Skin disease spectrum (dermatic cancer progression) tissue array, 79 cases 80 cores US Biomax 266 SK805 Skin disease spectrum (dermatic cancer progression) tissue array, 79 cases 80 cores US Biomax 266
ASK
Publication
SM2081 Small intestine disease (cancer progression) spectrum tissue array, 95 cases 208 cores US Biomax 456 SM2081 Small intestine disease (cancer progression) spectrum tissue array, 95 cases 208 cores US Biomax 456
ASK
Publication
SP1001 Spleen disease spectrum (splenic cancer progression) tissue array, 50 cases 100 cores US Biomax 266 SP1001 Spleen disease spectrum (splenic cancer progression) tissue array, 50 cases 100 cores US Biomax 266
ASK
Publication
TE803 Testis disease spectrum (testicular cancer progression) tissue array, 80 cases 80 cores US Biomax 266 TE803 Testis disease spectrum (testicular cancer progression) tissue array, 80 cases 80 cores US Biomax 266
ASK
Publication
THY761 Thymus disease spectrum (thymic cancer progression) tissue array, 76 cases 76 cores US Biomax 266 THY761 Thymus disease spectrum (thymic cancer progression) tissue array, 76 cases 76 cores US Biomax 266
ASK
Publication
UV1001 Vulval disease spectrum (vulva cancer progression) tissue array, 46 cases 100 cores US Biomax 266 UV1001 Vulval disease spectrum (vulva cancer progression) tissue array, 46 cases 100 cores US Biomax 266
ASK
Publication
OR801 Parotid gland disease spectrum (parotidean cancer progression) tissue array, 80 cases 80 cores US Biomax 266 OR801 Parotid gland disease spectrum (parotidean cancer progression) tissue array, 80 cases 80 cores US Biomax 266
ASK
Publication
SO1001 Peripheral nerve disease spectrum (peripheroneural cancer progression) tissue array, 50 cases 100 cores US Biomax 266 SO1001 Peripheral nerve disease spectrum (peripheroneural cancer progression) tissue array, 50 cases 100 cores US Biomax 266
ASK
Publication
TE2081 Testis disease spectrum (testicular cancer progression) tissue array, with TNM data, 104 cases 208 cores US Biomax 456 TE2081 Testis disease spectrum (testicular cancer progression) tissue array, with TNM data, 104 cases 208 cores US Biomax 456
ASK
Publication
UR1001 Ureter and urethra disease spectrum tissue array, with stage, grade and TNM data, 50 cases 100 cores US Biomax 199 UR1001 Ureter and urethra disease spectrum tissue array, with stage, grade and TNM data, 50 cases 100 cores US Biomax 199
ASK
Publication
BC03002 Liver disease spectrum tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores US Biomax 266 BC03002 Liver disease spectrum tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores US Biomax 266
ASK
Publication
BC04002 Lung disease spectrum tissue array, including TNM, clinical stage and pathology grade, 99 cases 100 cores US Biomax 266 BC04002 Lung disease spectrum tissue array, including TNM, clinical stage and pathology grade, 99 cases 100 cores US Biomax 266
ASK
Publication
BC05002 Colon disease spectrum tissue array, including TNM, clinical stage and pathology grade, 79 cases 80 cores US Biomax 266 BC05002 Colon disease spectrum tissue array, including TNM, clinical stage and pathology grade, 79 cases 80 cores US Biomax 266
ASK
Publication
BR722 Breast disease spectrum tissue array, 66 cases 72 cores, including normal, precancerous and cancer in different stages US Biomax 231 BR722 Breast disease spectrum tissue array, 66 cases 72 cores, including normal, precancerous and cancer in different stages US Biomax 231
ASK
Publication
MC631 Multiple organ, diseased tissue array (63 cases 63 cores, 20 types of cancer and disease), replacing BC00014 US Biomax 160 MC631 Multiple organ, diseased tissue array (63 cases 63 cores, 20 types of cancer and disease), replacing BC00014 US Biomax 160
ASK
Publication
PR8011 Prostate disease spectrum tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing PR805 US Biomax 314 PR8011 Prostate disease spectrum tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing PR805 US Biomax 314
ASK
Publication
A80059Mu01 Antibody to Parkinson Disease Protein 7 (PARK7) Organism: Mus musculus (Mouse) Type: Polyclonal Source: Rabbit USCNLife 50ug 340 A80059Mu01 Antibody to Parkinson Disease Protein 7 (PARK7) Organism: Mus musculus (Mouse) Type: Polyclonal Source: Rabbit USCNLife 50ug 340
ASK
Publication
BR1003 Breast pre cancerous disease and cancer tissue array (100 cases 101 cores), with clinical stage and pathology grade data US Biomax 266 BR1003 Breast pre cancerous disease and cancer tissue array (100 cases 101 cores), with clinical stage and pathology grade data US Biomax 266
ASK
Publication
SK245 Skin disease tissue array, including TNM, clinical stage and pathology grade, 24 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105 SK245 Skin disease tissue array, including TNM, clinical stage and pathology grade, 24 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
290-62601 Beta Amyloid (42) ELISA Kit, Human Rat Alzheimer''s Disease (AD) is characterized by the presence of extracellular senile plaques (SPs) and intracellular neurofibrillary tangles (NFT) in the brain. Th B-Bridge 96 tests 1040.55 290-62601 Beta Amyloid (42) ELISA Kit, Human Rat Alzheimer''s Disease (AD) is characterized by the presence of extracellular senile plaques (SPs) and intracellular neurofibrillary tangles (NFT) in the brain. Th B-Bridge 96 tests 1040.55
ASK
Publication
292-62301 Beta Amyloid (1 40) ELISA Kit, Human Alzheimer''s Disease (AD) is characterized by the presence of extracellular senile plaques (SPs) and intracellular neurofibrillary tangles (NFT) in the brain. The B-Bridge 96 tests 1040.55 292-62301 Beta Amyloid (1 40) ELISA Kit, Human Alzheimer''s Disease (AD) is characterized by the presence of extracellular senile plaques (SPs) and intracellular neurofibrillary tangles (NFT) in the brain. The B-Bridge 96 tests 1040.55
ASK
Publication
294-62501 Beta Amyloid (40) ELISA Kit, Human Rat Alzheimer''s Disease (AD) is characterized by the presence of extracellular senile plaques (SPs) and intracellular neurofibrillary tangles (NFT) in the brain. Th B-Bridge 96 tests 1040.55 294-62501 Beta Amyloid (40) ELISA Kit, Human Rat Alzheimer''s Disease (AD) is characterized by the presence of extracellular senile plaques (SPs) and intracellular neurofibrillary tangles (NFT) in the brain. Th B-Bridge 96 tests 1040.55
ASK
Publication
298-64601 Beta Amyloid (1 40) ELISA Kit II, Human Alzheimer''s Disease (AD) is characterized by the presence of extracellular senile plaques (SPs) and intracellular neurofibrillary tangles (NFT) in the brain. T B-Bridge 96 tests 1040.55 298-64601 Beta Amyloid (1 40) ELISA Kit II, Human Alzheimer''s Disease (AD) is characterized by the presence of extracellular senile plaques (SPs) and intracellular neurofibrillary tangles (NFT) in the brain. T B-Bridge 96 tests 1040.55
ASK
Publication
BR963 Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her 2, Ki67, CK14 and p53), 48 cases 96 cores, replacing BR962 US Biomax 314 BR963 Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her 2, Ki67, CK14 and p53), 48 cases 96 cores, replacing BR962 US Biomax 314
ASK
Publication
BR480 Breast disease spectrum tissue array progression array, 48 cases 48 cores US Biomax 314 BR480 Breast disease spectrum tissue array progression array, 48 cases 48 cores US Biomax 314
ASK
Publication
LM801 Lymphoma (Hodgkin's and non Hodgkin's disease) tissue array, 80 cases 80 cores US Biomax 266 LM801 Lymphoma (Hodgkin's and non Hodgkin's disease) tissue array, 80 cases 80 cores US Biomax 266
ASK
Publication
SFD241 Human soft tissue disease tissue array, 24 cases 24 cores US Biomax 166 SFD241 Human soft tissue disease tissue array, 24 cases 24 cores US Biomax 166
ASK
Publication
BL2082 Bladder disease spectrum (bladder cancer progression) tissue array, 202 cases 208 cores US Biomax 456 BL2082 Bladder disease spectrum (bladder cancer progression) tissue array, 202 cases 208 cores US Biomax 456
ASK
Publication
BO2081 Bone disease spectrum (bone tumor progression) tissue array, 104 cases 208 cores US Biomax 516 BO2081 Bone disease spectrum (bone tumor progression) tissue array, 104 cases 208 cores US Biomax 516
ASK
Publication
BR2082 Breast disease spectrum (breast cancer progression) tissue array, 206 cases 208 cores US Biomax 456 BR2082 Breast disease spectrum (breast cancer progression) tissue array, 206 cases 208 cores US Biomax 456
ASK
Publication
CIN481 Cervical intraepithelial neoplasia tissue array with cervical disease spectrum, 48 cases 48 cores US Biomax 225 CIN481 Cervical intraepithelial neoplasia tissue array with cervical disease spectrum, 48 cases 48 cores US Biomax 225
ASK
Publication
CO808 Colon disease spectrum (colon cancer progression) tissue array, 76 cases 80 cores US Biomax 266 CO808 Colon disease spectrum (colon cancer progression) tissue array, 76 cases 80 cores US Biomax 266
ASK
Publication
ES809 Esophageal disease spectrum (esophageal cancer progression) tissue array, 78 cases 80 cores US Biomax 231 ES809 Esophageal disease spectrum (esophageal cancer progression) tissue array, 78 cases 80 cores US Biomax 231
ASK
Publication
GA801 Gallbladder disease spectrum (gallbladder cancer progression) tissue array, 80 cases 80 cores US Biomax 123 GA801 Gallbladder disease spectrum (gallbladder cancer progression) tissue array, 80 cases 80 cores US Biomax 123
ASK
Publication
HE1001 Heart disease spectrum (heart tumor progression) tissue array, 50 cases 100 cores US Biomax 266 HE1001 Heart disease spectrum (heart tumor progression) tissue array, 50 cases 100 cores US Biomax 266
ASK
Publication
LM802 Lymphoma (Hodgkin's and non Hodgkin's disease) tissue array, 80 cases 80 cores, replaced by NHL803 US Biomax 266 LM802 Lymphoma (Hodgkin's and non Hodgkin's disease) tissue array, 80 cases 80 cores, replaced by NHL803 US Biomax 266
ASK
Publication
NH1001 Nasopharynx disease spectrum (nasopharynx cancer progression) tissue array, 49 cases 100 cores US Biomax 266 NH1001 Nasopharynx disease spectrum (nasopharynx cancer progression) tissue array, 49 cases 100 cores US Biomax 266
ASK
Publication
OR1001 Tonsil disease spectrum (tonsil tumor progression) tissue array, 50 cases 100 cores US Biomax 266 OR1001 Tonsil disease spectrum (tonsil tumor progression) tissue array, 50 cases 100 cores US Biomax 266
ASK
Publication
PE601 Penis disease spectrum (penis tumor progression) tissue array, 59 cases 60 cores US Biomax 266 PE601 Penis disease spectrum (penis tumor progression) tissue array, 59 cases 60 cores US Biomax 266
ASK
Publication
ST1001 Stomach disease spectrum (stomach cancer progression) tissue array, 100 cases 100 cores US Biomax 266 ST1001 Stomach disease spectrum (stomach cancer progression) tissue array, 100 cases 100 cores US Biomax 266
ASK
Publication
UT801 Endometrial disease spectrum (endometrial cancer progression) tissue array, 80 cases 80 cores US Biomax 278 UT801 Endometrial disease spectrum (endometrial cancer progression) tissue array, 80 cases 80 cores US Biomax 278
ASK
Publication
AD2081 Adrenal gland disease spectrum (adrenal cancer progression) tissue array, 100 cases 200 cores US Biomax 456 AD2081 Adrenal gland disease spectrum (adrenal cancer progression) tissue array, 100 cases 200 cores US Biomax 456
ASK
Publication
OR2081 Oral cavity disease spectrum (oral cancer progression) tissue array, 98 cases 208 cores US Biomax 456 OR2081 Oral cavity disease spectrum (oral cancer progression) tissue array, 98 cases 208 cores US Biomax 456
ASK
Publication
ST8011 Gastric cardia disease spectrum (cardia cancer progression) tissue array, 80 cases 80 cores US Biomax 266 ST8011 Gastric cardia disease spectrum (cardia cancer progression) tissue array, 80 cases 80 cores US Biomax 266
ASK
Publication
BR963a Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores, replacing BR963; ihc Anti-Actin confirmed US Biomax 296 BR963a Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores, replacing BR963; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
OV1001 Ovarian disease spectrum (ovarian cancer progression) tissue array, 100 cases 100 cores, replaced by OV1005 US Biomax 231 OV1001 Ovarian disease spectrum (ovarian cancer progression) tissue array, 100 cases 100 cores, replaced by OV1005 US Biomax 231
ASK
Publication
SO8011 Smooth muscle and striated muscle disease spectrum (cancer progression) tissue array, 80 cases 80 cores US Biomax 278 SO8011 Smooth muscle and striated muscle disease spectrum (cancer progression) tissue array, 80 cases 80 cores US Biomax 278
ASK
Publication
BC06002 Rectum disease spectrum (rectum cancer progression) tissue array, including TNM and pathology grade, 63 cases 72 cores US Biomax 321 BC06002 Rectum disease spectrum (rectum cancer progression) tissue array, including TNM and pathology grade, 63 cases 72 cores US Biomax 321
ASK
Publication
BC07001 Kidney disease spectrum (kidney cancer progression) tissue array, including TNM and pathology grade, 40 cases 80 cores US Biomax 321 BC07001 Kidney disease spectrum (kidney cancer progression) tissue array, including TNM and pathology grade, 40 cases 80 cores US Biomax 321
ASK
Publication
CNS801 Brain disease spectrum (brain cancer progression) tissue array, with stage, TNM and grade info, 79 cases 80 cores US Biomax 314 CNS801 Brain disease spectrum (brain cancer progression) tissue array, with stage, TNM and grade info, 79 cases 80 cores US Biomax 314
ASK
Publication
CO2081 Colon disease spectrum (colon cancer progression) tissue array, including TNM and pathology grade, 103 cases 208 cores US Biomax 456 CO2081 Colon disease spectrum (colon cancer progression) tissue array, including TNM and pathology grade, 103 cases 208 cores US Biomax 456
ASK
Publication
PA2081 Pancreatic disease spectrum (pancreatic cancer progression) tissue array with pathology grade and TNM information, 101 cases 208 cores US Biomax 456 PA2081 Pancreatic disease spectrum (pancreatic cancer progression) tissue array with pathology grade and TNM information, 101 cases 208 cores US Biomax 456
ASK
Publication
CR601 Cervical carcinoma tissue array with cervical disease spectrum (normal, inflammation, CIN, malignant I III), 59 cases 60 cores, replaced by CR602 US Biomax 231 CR601 Cervical carcinoma tissue array with cervical disease spectrum (normal, inflammation, CIN, malignant I III), 59 cases 60 cores, replaced by CR602 US Biomax 231
ASK
Publication
LM208 High density tissue microarray of Hodgkin's Disease, Non Hodgkin's lymphoma and normal lymph node tissues, 69 cases 208 cores US Biomax 456 LM208 High density tissue microarray of Hodgkin's Disease, Non Hodgkin's lymphoma and normal lymph node tissues, 69 cases 208 cores US Biomax 456
ASK
Publication
OV1005a Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1005; ihc Anti-Actin confirmed US Biomax 267 OV1005a Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1005; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
MGS801 Male genitourinary system tissue array with normal, inflammation, disease and cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores US Biomax 266 MGS801 Male genitourinary system tissue array with normal, inflammation, disease and cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores US Biomax 266
ASK
Publication
OV1005 Ovarian disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1001 US Biomax 266 OV1005 Ovarian disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1001 US Biomax 266
ASK
Publication
SO2081 Muscle disease spectrum (smooth muscle and striated muscle cancer progression) tissue array, 104 cases 208 cores US Biomax 456 SO2081 Muscle disease spectrum (smooth muscle and striated muscle cancer progression) tissue array, 104 cases 208 cores US Biomax 456
ASK
Publication
BO801 Bone and cartilage disease spectrum (bone and cartilage cancer progression) tissue array, 80 cases 80 cores US Biomax 266 BO801 Bone and cartilage disease spectrum (bone and cartilage cancer progression) tissue array, 80 cases 80 cores US Biomax 266
ASK
Publication
CNS2081 Central nerve disease spectrum (central nerve tumor progression) tissue array, 104 cases 208 cores US Biomax 516 CNS2081 Central nerve disease spectrum (central nerve tumor progression) tissue array, 104 cases 208 cores US Biomax 516
ASK
Publication
OR802 Oral cavity disease spectrum (oral cavity cancer progression) tissue array, 79 cases 80 cores US Biomax 266 OR802 Oral cavity disease spectrum (oral cavity cancer progression) tissue array, 79 cases 80 cores US Biomax 266
ASK
Publication
SO8010 Blood vessel disease spectrum (blood vessel cancer progression) tissue array, 80 cases 80 cores US Biomax 266 SO8010 Blood vessel disease spectrum (blood vessel cancer progression) tissue array, 80 cases 80 cores US Biomax 266
ASK
Publication
UTE601 Fallopian tube disease spectrum (fallopian tube cancer progression) tissue array, 30 cases 60 cores US Biomax 266 UTE601 Fallopian tube disease spectrum (fallopian tube cancer progression) tissue array, 30 cases 60 cores US Biomax 266
ASK
Publication
VA1001 Vermiform appendix disease spectrum (vermiform appendix tumor progression) tissue array, 50 cases 100 cores US Biomax 266 VA1001 Vermiform appendix disease spectrum (vermiform appendix tumor progression) tissue array, 50 cases 100 cores US Biomax 266
ASK
Publication
SM802 Small intestine disease spectrum (small intestine cancer progression) tissue array, with grade, stage and TNM data, 72 cases 80 cores US Biomax 266 SM802 Small intestine disease spectrum (small intestine cancer progression) tissue array, with grade, stage and TNM data, 72 cases 80 cores US Biomax 266
ASK
Publication
SO2083 Adipose tissue disease spectrum (adipose tumor progression) tissue array, 104 cases 208 cores US Biomax 456 SO2083 Adipose tissue disease spectrum (adipose tumor progression) tissue array, 104 cases 208 cores US Biomax 456
ASK
Publication
CR602 Tissue array of uterine cervical disease spectrum (cervical cancer, CIN, inflammation and adjacent normal tissue), 60 cases 60 cores, replacing CR601 US Biomax 231 CR602 Tissue array of uterine cervical disease spectrum (cervical cancer, CIN, inflammation and adjacent normal tissue), 60 cases 60 cores, replacing CR601 US Biomax 231
ASK
Publication
SO2084 Fibrous tissue disease spectrum (fibrous tissue cancer progression) tissue array, 104 cases 208 cores US Biomax 456 SO2084 Fibrous tissue disease spectrum (fibrous tissue cancer progression) tissue array, 104 cases 208 cores US Biomax 456
ASK
Publication
orb82514 FIV Core Ag, recombinant protein Feline Immunodeficiency Virus (FIV) Core Antigen, Recombinant is an infectious disease antigen toxin. For research use only. Biorb 100 768 orb82514 FIV Core Ag, recombinant protein Feline Immunodeficiency Virus (FIV) Core Antigen, Recombinant is an infectious disease antigen toxin. For research use only. Biorb 100 768
ASK
Publication
orb82396 Toxoplasma gondii GRA8, recombinant protein Toxoplasma gondii GRA8, Recombinant is an infectious disease antigen toxin. For research use only. Biorb 1 mg 784 orb82396 Toxoplasma gondii GRA8, recombinant protein Toxoplasma gondii GRA8, Recombinant is an infectious disease antigen toxin. For research use only. Biorb 1 mg 784
ASK
Publication
  Cat_Number Product name Supplier Quantity Price Tech More